Skip to content

OPEN Foundation

Menu

Therapist Training
- ADEPT
- Foundations
  - Curriculum
  - Faculty
  - Enrolment
  - FAQ
Conference
Community
Events
- Workshop: Ketamine-Assisted Psychotherapy (KAP)
Articles & News
About
- Team
- Vacancies
Contact
Donate
Member Login

Search

Articles & News

Search

Search

Scientific Discipline
Substance
Therapeutic Application

Psilocybin: panacea or placebo?

August 24, 2016

Question-based Drug Development for psilocybin – Authors’ reply

August 24, 2016

Question-based Drug Development for psilocybin – Authors' reply

August 24, 2016

Question-based Drug Development for psilocybin

August 24, 2016

Return of the psychedelics: Psilocybin for treatment resistant depression

August 23, 2016

The antidepressant effect of ketamine: Mediated by AMPA receptors?

August 20, 2016

Psilocybin for treating substance use disorders?

August 12, 2016

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

August 11, 2016

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society

August 11, 2016

Semantic activation in LSD: evidence from picture naming

August 11, 2016

OPEN is a public benefit organisation (ANBI) and registered charity with the Dutch tax authorities.

Linkedin Twitter Facebook-f Instagram Youtube

OPEN

About
Events
Programmes
Resources
Blog
Newsletter
Privacy Policy
Terms & Conditions
Klachtenregeling
Contact

ABOUT

Mission
Team
Partners
FAQs
Nonprofit Status
Financial Reports
Indegeest Network
Working Group GGZ

EVENTS

ICPR Conference
Online Events
On-site Events

RESOURCES

Talks
Papers
Books

PROGRAMMES

Membership
Training
Research

ACTIONS

Participate
Vacancies
Donate

© 2007-2024 OPEN Foundation

Placebo Effects & Blinding in Psychedelic Trials - September 8